Xxec, Inc. Pfizer Inc Transaction History

Xxec, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$25.26 - $29.6 $56,835 - $66,600	-2,250 Reduced 1.31%	169,942 $4.75 Million
Q1 2024 Apr 22, 2024	BUY	$25.89 - $29.73 $4,919 - $5,648	190 Added 0.11%	172,192 $4.78 Million
Q4 2023 Jan 24, 2024	BUY	$26.13 - $33.94 $667,229 - $866,657	25,535 Added 17.43%	172,002 $4.95 Million
Q3 2023 Nov 08, 2023	BUY	$32.09 - $37.51 $505,642 - $591,045	15,757 Added 12.05%	146,467 $4.86 Million
Q2 2023 Aug 02, 2023	SELL	$36.12 - $41.79 $93,912 - $108,654	-2,600 Reduced 1.95%	130,710 $4.79 Million
Q1 2023 May 08, 2023	BUY	$39.39 - $51.28 $828,804 - $1.08 Million	21,041 Added 18.74%	133,310 $5.44 Million
Q3 2022 Nov 04, 2022	SELL	$43.76 - $53.42 $572,205 - $698,519	-13,076 Reduced 10.43%	112,269 $4.91 Million
Q3 2021 Oct 19, 2021	SELL	$39.25 - $50.42 $3,179 - $4,084	-81 Reduced 0.06%	125,345 $5.39 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $359 - $406	-10 Reduced 0.01%	125,426 $4.91 Million
Q1 2021 Apr 16, 2021	BUY	$33.49 - $37.77 $1.67 Million - $1.89 Million	50,000 Added 66.28%	125,436 $4.55 Million
Q4 2020 Feb 17, 2021	BUY	$33.47 - $42.56 $2.52 Million - $3.21 Million	75,436 New	75,436 $2.78 Million

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Xxec, Inc., based on Form 13F filings with the SEC.

Stay updated on Xxec, Inc. with notifications on news.